https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-442011-04-06 00:00:002011-04-06 00:00:00Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-01-01 / Therapy 2011 Jan;8(1):43-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-01-01 / Therapy 2011 Jan;8(1):43-542011-01-01 00:00:002019-02-15 08:35:15Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-03-12 / Lung Cancer 2010 Nov;70(2):188-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-03-12 / Lung Cancer 2010 Nov;70(2):188-942010-03-12 00:00:002019-02-15 08:45:35Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-13 / Gen Thorac Cardiovasc Surg 2009 Sep;57(9):449-572009-09-13 00:00:002019-02-15 08:34:56Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-92008-12-13 00:00:002008-12-13 00:00:00Mechanisms of murine dendritic cell antitumor dysfunction in aging
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-82008-12-04 00:00:002019-02-15 08:34:57Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-07-11 / Lung Cancer 2009 Feb;63(2):247-502008-07-11 00:00:002019-02-15 08:34:58Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-807
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-06 / Cancer Gene Ther. 2008 Dec;15(12):795-8072008-06-06 00:00:002008-06-06 00:00:00Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-312008-06-01 00:00:002019-02-15 08:35:00Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-242008-06-01 00:00:002019-02-15 08:35:00IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
